Bench Study Highlights Performance Edge for Bright Uro’s Glean System

According to a recent LinkedIn post from Bright Uro, a head-to-head bench study is described comparing the company’s Glean pressure sensors with Laborie T-doc air-charged catheters in a simulated human bladder model. The post indicates that 30 Glean sensors and 30 traditional catheters were evaluated on response time, bandwidth, maximum error, and linearity.

The company’s LinkedIn post reports that Glean outperformed the traditional catheter on all four metrics, with differences described as statistically significant at p < 0.001. The post further suggests that the Glean system may deliver equal or better diagnostic performance than traditional catheters while also being preferred by patients over conventional urodynamics. For investors, the reported performance advantages could support Bright Uro’s value proposition in urodynamics, potentially strengthening its competitive position against established devices. If clinicians and healthcare systems validate and adopt these findings in practice, the company could benefit from increased utilization, pricing power, and a larger addressable market in diagnostic urology. The reference to a published article linked in the post may help substantiate the technology’s claims in peer-reviewed settings, which is often important for reimbursement and clinical guideline inclusion. Over time, demonstrated accuracy and patient preference, if replicated in broader clinical use, could translate into stronger revenue visibility and enhance Bright Uro’s standing as an innovation-focused player in urology diagnostics.